Anorectal lymphoma and AIDS: an outcome analysis

Area of Science:

• Oncology
• Infectious Diseases
• Gastroenterology

Background:

• Primary anorectal non-Hodgkin's lymphoma (NHL) is exceptionally rare.
• Patients with Acquired Immune Deficiency Syndrome (AIDS) exhibit a significantly higher incidence of gastrointestinal NHL.
• This study focuses on the outcomes of individuals with co-occurring anorectal NHL and AIDS.

Purpose of the Study:

• To investigate the clinical outcomes of patients diagnosed with anorectal NHL in the context of AIDS.
• To assess the impact of specific symptoms and treatment modalities on patient prognosis.

Main Methods:

• A retrospective analysis of 6 patients with AIDS and primary anorectal NHL over an 18-year period.
• Patient data included lymphoma grade, presence of systemic "B" symptoms, and CD4 counts.
• Treatment responses to radiation and chemotherapy were evaluated.

Main Results:

• Patients with "B" symptoms had a shorter average lifespan (6.7 months) compared to those without (16 months).
• Radiation and chemotherapy showed no significant benefit for patients presenting with "B" symptoms.
• Younger patients and those without systemic symptoms demonstrated better outcomes, with one patient achieving disease-free status.

Conclusions:

• Anorectal NHL in AIDS patients with "B" symptoms carries a poor prognosis despite standard NHL treatments.
• Remission is achievable for patients without "B" symptoms who can tolerate therapy.
• The findings highlight the importance of symptom presentation in predicting treatment success for anorectal NHL in the AIDS population.